World's Best Scientists 2026 revealed!
Juan Miguel Mosquera

Juan Miguel Mosquera

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
24698
World Ranking
15342
National Ranking
6401

Overview

Juan Miguel Mosquera is affiliated with Cornell University in the United States. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a primary focus on topics related to cancer biology and genomics.

The main subfields of their work include Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology, and Surgery. Their research topics are concentrated on Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Genetic Factors in Colorectal Cancer, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment, and Epigenetics and DNA Methylation.

Juan Miguel Mosquera has published extensively in a variety of scientific journals and venues. Frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Pathology - Research and Practice
  • Laboratory Investigation
  • npj Precision Oncology

Recent papers include:

  • Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs, 2020, Cell
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets, 2022, Science
  • Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer, 2020, Journal of Clinical Investigation
  • Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing, 2022, Nature Biotechnology
  • Unsupervised discovery of tissue architecture in multiplexed imaging, 2022, Nature Methods

Frequent co-authors collaborating with Juan Miguel Mosquera include:

  • Olivier Elemento
  • Andrea Sboner
  • Michael Sigouros
  • Jyothi Manohar
  • David Wilkes

Best Publications

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

    Garrett M Frampton;Alex Fichtenholtz;Geoff A Otto;Kai Wang

  • Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

    Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis

  • Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

    Himisha Beltran;Himisha Beltran;Davide Prandi;Juan Miguel Mosquera;Juan Miguel Mosquera;Matteo Benelli

  • Organoid cultures derived from patients with advanced prostate cancer

    Dong Gao;Ian Vela;Andrea Sboner;Phillip J Iaquinta

  • Punctuated Evolution of Prostate Cancer Genomes

    Sylvan C Baca;Davide Prandi;Michael S Lawrence;Juan Miguel Mosquera

  • Genomic correlates of clinical outcome in advanced prostate cancer.

    Wassim Abida;Joanna Cyrta;Joanna Cyrta;Glenn Heller;Davide Prandi

  • Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

    Chantal Pauli;Chantal Pauli;Chantal Pauli;Benjamin D Hopkins;Davide Prandi;Reid Shaw

  • TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

    F. Demichelis;K. Fall;S. Perner;S. Perner;O. Andrén

  • Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Dan R. Robinson;Yi Mi Wu;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Xuhong Cao

  • TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

    Sven Perner;Sven Perner;Francesca Demichelis;Rameen Beroukhim;Rameen Beroukhim;Folke H. Schmidt

  • The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

    Dimple Chakravarty;Andrea Sboner;Sujit S. Nair;Eugenia Giannopoulou

  • TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

    Sven Perner;Sven Perner;Juan Miguel Mosquera;Francesca Demichelis;Matthias D. Hofer

  • Proposed morphologic classification of prostate cancer with neuroendocrine differentiation

    Jonathan I. Epstein;Mahul B. Amin;Himisha Beltran;Tamara L. Lotan

  • Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity

    Himisha Beltran;Roman Yelensky;Garrett M. Frampton;Kyung Park

  • Erratum: Integrative Clinical Genomics of Advanced Prostate Cancer

    Dan Robinson;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.

    Cristina R. Antonescu;Francois Le Loarer;Juan-Miguel Mosquera;Andrea Sboner

  • N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

    Etienne Dardenne;Himisha Beltran;Matteo Benelli;Kaitlyn Gayvert

  • Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.

    Himisha Beltran;Himisha Beltran;Kenneth Eng;Kenneth Eng;Juan Miguel Mosquera;Juan Miguel Mosquera;Alexandros Sigaras

  • Patient derived organoids to model rare prostate cancer phenotypes

    Loredana Puca;Loredana Puca;Rohan Bareja;Rohan Bareja;Davide Prandi;Reid Shaw

Frequent Co-Authors

Mark A. Rubin
Mark A. Rubin University of Bern
Himisha Beltran
Himisha Beltran Harvard University
Andrea Sboner
Andrea Sboner Cornell University
Olivier Elemento
Olivier Elemento Cornell University
Francesca Demichelis
Francesca Demichelis University of Trento
David M. Nanus
David M. Nanus Cornell University
Levi A. Garraway
Levi A. Garraway Roche (United States)
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Sven Perner
Sven Perner University of Lübeck
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a diverse range of online degrees and evolving career pathways. If you’re looking for opportunities that blend science with technology and healthcare, options like medical coding, health information management, and nutrition are worth exploring.

Many students ask, how long does it take to become a medical coder? The answer varies depending on the program, but online diploma and certificate pathways can lead to entry-level jobs in as little as a year. Those considering the next step often wonder, is medical billing and coding worth it? Career satisfaction depends on factors such as work-life balance, job stability, and the ability to work remotely.

If you’re interested in technology-driven healthcare, pursuing a bachelor's degree health information management could be a strategic move. This field merges data science with patient care, supporting the backbone of healthcare systems. Alternatively, for those passionate about diet and wellness, enrolling in one of the cheapest online nutrition degree programs can make advanced education more accessible.

Whether your interests lie in coding, management, or nutrition, these online education options provide flexibility, affordability, and strong career prospects in the growing health sciences field.

Best Scientists Citing Juan Miguel Mosquera

Trending Scientists